SAN DIEGO, Sept. 26, 2023 (GLOBE NEWSWIRE) — Ambrx Biopharma Inc., Ambrx (or the “Company”) AMAM, today announced that it will host an in-person key opinion leader (KOL) event during the European Society for Medical Oncology (ESMO) Congress 2023. The event will take place on Sunday, October 22, 2023 from…Read More
Ambrx to Host KOL Event Discussing ARX517 Data Presented at ESMO Congress 2023 Ambrx Biopharma NASDAQAMAM
